Literature DB >> 9392001

Recent advances in the treatment of malignant melanoma with gene therapy.

E M Hersh1, A T Stopeck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9392001      PMCID： PMC2230237     

Source DB:  PubMed          Journal:  Mol Med        ISSN： 1076-1551            Impact factor:   6.354


× No keyword cloud information.
  100 in total

1.  Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.

Authors:  J Rubin; E Galanis; H C Pitot; R L Richardson; P A Burch; J W Charboneau; C C Reading; B D Lewis; S Stahl; E T Akporiaye; D T Harris
Journal:  Gene Ther       Date:  1997-05       Impact factor: 5.250

2.  Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells.

Authors:  M F Ledda; S Adris; A I Bravo; C Kairiyama; L Bover; Y Chernajovsky; J Mordoh; O L Podhajcer
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

3.  The TMC Worldwide Gene Therapy Enrollment Report, end 1996.

Authors:  T Marcel; J D Grausz
Journal:  Hum Gene Ther       Date:  1997-04-10       Impact factor: 5.695

Review 4.  The development of new cancer therapies based on the molecular identification of cancer regression antigens.

Authors:  S A Rosenberg
Journal:  Cancer J Sci Am       Date:  1995 Jul-Aug

5.  Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model.

Authors:  D W Ju; X Cao; B Acres
Journal:  Cancer Gene Ther       Date:  1997 Mar-Apr       Impact factor: 5.987

6.  Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.

Authors:  J N Cormier; M L Salgaller; T Prevette; K C Barracchini; L Rivoltini; N P Restifo; S A Rosenberg; F M Marincola
Journal:  Cancer J Sci Am       Date:  1997 Jan-Feb

7.  Interleukin 10 production by human melanoma.

Authors:  T Sato; P McCue; K Masuoka; S Salwen; E C Lattime; M J Mastrangelo; D Berd
Journal:  Clin Cancer Res       Date:  1996-08       Impact factor: 12.531

8.  Decreased antigen presentation by dendritic cells in patients with breast cancer.

Authors:  D I Gabrilovich; J Corak; I F Ciernik; D Kavanaugh; D P Carbone
Journal:  Clin Cancer Res       Date:  1997-03       Impact factor: 12.531

9.  Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.

Authors:  K Kono; M E Ressing; R M Brandt; C J Melief; R K Potkul; B Andersson; M Petersson; W M Kast; R Kiessling
Journal:  Clin Cancer Res       Date:  1996-11       Impact factor: 12.531

10.  Alterations in T cell receptor and signal transduction molecules in melanoma patients.

Authors:  A H Zea; B D Curti; D L Longo; W G Alvord; S L Strobl; H Mizoguchi; S P Creekmore; J J O'Shea; G C Powers; W J Urba
Journal:  Clin Cancer Res       Date:  1995-11       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.